NGRN

Across TCGA pan-cancer cohorts, NGRN mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of NGRN’s most consistent transcriptional readouts.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where NGRN mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types NGRN is over-expressed in tumor, although a few such as CCRCC and PDAC show the opposite, repressed pattern.

CCRCC, PDAC, and LUAD are the cancer types where NGRN tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in NGRN mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CCRCC	Male	All	−0.501	<.001	10	view →
PDAC	All	All	−0.497	<.001	6	view →
LUAD	Male	All	+0.231	<.001	4	view →
LSCC	Male	All	+0.337	<.001	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

NGRN–CCRCC

Open the CCRCC breakdown →